Topics:
Lung Cancer • Thoracic Malignancies • Medical Oncology • Rheumatology • Rheumatoid Arthritis
How would you treat active rheumatoid arthritis in a patient in complete response on loralatinib for stage IV ALK positive NSCLC?
Patient already on methotrexate and plaquenil.
Answer from: at Academic Institution
I would do my best to minimize immunosuppression. I would use IL-6 or Abatacept and possibly rituximab. Have done all to minimize DMARDs and have had success with all 3.
Sign in or Register to read more